Apellis Pharmaceuticals, Inc. (APLS)
19.94
-0.59
(-2.87%)
USD |
NASDAQ |
Jan 16, 16:00
20.05
+0.11
(+0.55%)
After-Hours: 20:00
Apellis Pharmaceuticals Market Cap: 2.523B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.421B |
| Alnylam Pharmaceuticals, Inc. | 47.46B |
| Ionis Pharmaceuticals, Inc. | 12.36B |
| Fortress Biotech, Inc. | 115.46M |
| Sarepta Therapeutics, Inc. | 2.214B |
Market Cap Related Metrics
| PE Ratio | 67.14 |
| PS Ratio | 2.482 |
| Price to Book Value | 6.289 |
| Price to Free Cash Flow | 32.08 |
| Price | 19.94 |
| Earnings Yield | 1.49% |
| Operating PE Ratio | 31.38 |
| Normalized PE Ratio | 67.14 |